BDBM306694 (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(4-fluorophenyl)-1,8- dimethyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-1,8- dimethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 339

SMILES Cc1cc(N)nc(C)c1CNC(=O)c1ccc2c(c1)C1(C)OC2(C)c2ccc(cc12)-c1ccc(F)cc1

InChI Key InChIKey=OSNZWWSEVQUWFO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 306694   

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandPNGBDBM306694(US10144746, Compound 339 | (+-)-N-[(6-amino-2,4- d...)
Affinity DataIC50: 1.00E+5nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent